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20.1 Introduction
Solubility is well recognized as a fundamental physical property for the design
of processes to separate, concentrate, and purify a targeted species. As will be
discussed in the next section food, pharmaceuticals, and cosmetic industries
frequently involve separation processes like precipitation, crystallization, liq-
uid–liquid or supercritical ﬂuid extraction (SFE). In each of these processes the
choice of solvent plays an important role; for instance, it is estimated that 30%
of the work of a thermodynamic group in a pharmaceutical company is directly
related to the solvent selection.1 As a result, we have decided to present this
chapter in terms of the solubility of pharmaceuticals, amino acids (AA),
proteins, or sugars in water, organic, and mixed solvents, liquid–liquid solu-
bility; mostly related to aqueous two-phase systems (ATPS), or water–octanol
partition coefﬁcients, and solubility in supercritical ﬂuids. The focus is, essen-
tially, on the most recent developments concerning solubility correlation and
prediction for substances of interest in those industries and processes. Exper-
imental aspects, although of extreme relevance, are only highlighted for some
speciﬁc cases where it is important to be aware of some particularities. In fact,
several issues about the measurement of solubility were recently subject to an
important edition.2 Finally, a global overview is presented, some suggestions
emphasized, and also some challenges for the near future are pointed out.
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20.2 Industrial Importance
Recently, Agrawal and Noble3 addressed some problems concerning separation
needs for the 21st century. Many of them are related to the pharmaceutical,
biomedical, and other biotech industries. In this context, researchers from Dow
Chemical Company pointed out crystallization, ATPS, and other similar
liquid–liquid extractions as processes of highest relevance.4
Excluding ethanol, antibiotics and AA are the major fermentation products
with a market value around US$ 8 billion in 2004.5 Their application in
pharmaceutical or food industries are numerous, and AA are also used in the
cosmetic industry. For instance, serine is employed for skin care cream or
lotion, and some histidine derivatives act as free anti-radical agents in cosmet-
ics.6 After fermentation, several puriﬁcation and separation techniques are
applied to those highly complex broths. Crystallization is often used, for
example, in glutamic acid or threonine production, for which solubility data
is fundamental. Apart from key separation issues like extraction and crystal-
lization, in pharmaceutical industries, solubility is also an essential property for
the design of new drugs. Aqueous solubility gives valuable indications about
the biological activity of a drug, and therefore, is most important in pre-
formulation studies.7 Water solubility, co-solvency and partition coefﬁcients
are topics under attention in many research and development groups at
companies like Mitsubishi Chemical Corporation,1 Merck and Zeneca Phar-
maceuticals,8 Hoﬀmann-La Roche,9 GlaxoWellcome,10 and Pﬁzer,11 to name a
few.
In the area of food processing, Agrawal and Noble3 focused on solving such
problems as the requirements of extremely high purity, and ﬂavor and aroma
capture. One of the technologies most studied in this area is the SFE with
several patents and applications; some examples are the removal of cholesterol
from food products,12 de-alcoholization of beverages,13 and concentration of
ﬂavor compounds.14 However, even if the ﬁnal sensory appreciation of ﬂavor
and aromas in food are much dependent on how the components are distrib-
uted over the different phases,15 phase equilibria in food product design is still
creating its basic foundations. Bruin,15 and researchers at Unilever Research,
applied a simple 2- or 3-sufﬁx Margules equation16 for the representation of the
solid–liquid equilibrium of three polymorphic forms of fat crystals, sharing its
success with the other well-known case, the solidiﬁcation of chocolate.17 A few
ﬁnal examples about research carried out for industrial needs are listed on
Table 1.
20.3 Water Solubility
Water is omnipresent in many reaction and separation processes in biotech-
nology, and as discussed previously, solubility of biomolecules is a key equi-
librium property in their production. Additionally, drug solubility in water
gives general trends for rates of dissolution; poor solubility is usually
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synonymous with a very low dissolution velocity.25 As a result, an administered
drug will mostly be excreted without the possibility of absorption from
gastrointestinal tract into the cardiovascular system.26 Besides the inherent
complexities with experimental measurements, for this type of molecules,
accuracy and reliability are specially difﬁcult to achieve, and measurements
are particularly time consuming. So, methods to predict water solubilities are
an important research subject, with an extraordinary value for drug design.
This task is, however, challenging because biomolecules are often very complex;
they possess high molecular weight, with two or more functional groups,
leading to a variety of complex molecular interactions, and are often present
in different structures or isomers.27
In order to satisfy conditions for satisfactory water solubility and membrane
permeability, drugs need to have the right balance between polarity and
hydrophobicity. Empirically, if log S(S is the drug aqueous solubility in mol
dm3) is in the range between -1 and -5, its adequacy is accepted.26 Several
methods to calculate log S for drugs have been proposed, but the correlations
based on physicochemical properties like the octanol-water partition coefﬁcient
(Pow) and the melting point are currently of little use. In fact, as will be brieﬂy
discussed in Section 5, to calculate Pow several reliable methods are known, but
for the melting point the opposite is true, and several reasons may hamper its
experimental measurement. Another approach is based on the group-contri-
bution concept, for which probably the most familiar is the AQUAFAC
method. However, it also has the disadvantage of needing the melting point,28
and even if several other methods that avoid this problem are available,
generally, the number of groups is not enough to represent the wider variety
Table 1 Some projects, involving solubility issues, carried out at different
companies
Problem Addressed Company Ref.
Effect of a-tocopherol on the solubilization of
poor soluble drugs in simulated intestinal ﬂuids
Dumex–Alpharma Nielsen et
al.18
Enrichment of Amaranth seed oil on high value
lipids by SFE
Unilever Westerman
et al.19
Find an efﬁcient excipient for rapamycin
(immunosuppressor)
Schering–Plough
HealthCare
Simamora
et al.20
Increase the average crystal size of
pharmaceuticals or agrochemicals by batch
crystallization
Rhone–Poulenc Lewiner et
al.21
Inﬂuence of water content on triglycerides and
their ability to be used as pharmaceutical
excipients of steroids
Proctor and Gamble
Novartis Pharmaceuticals
Land et
al.22
Study of the solubility and partition coefﬁcients
of surfactants in several solvent systems to design
initial extraction processes
Merck Pollard et
al.23
Study of ethanol as co-solvent in the
crystallization of 1,3-dihydroxyacetone for
application in the cosmetic industry
Ard–Soliance Zhu et al.24
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of drugs under development nowadays. Multiple linear regression (MLR) and
neural networks (NN) are two other techniques applied for solubility predic-
tions. They are both based on a set of different descriptors like molecular
weight, solvent-accessible surface area, and many other topological and elec-
tronic indices. While NN allows the introduction of non-linearity for the
descriptors terms in the solubility equation, which is an advantage to MLR,
it is a black box type method that cannot provide insights for drug lead
optimization except by trial and error.26 In addition, over-training is a major
issue for NN techniques, and its predictive capabilities are, most of the times,
no better than that of MLR. Several different equations have been proposed
and reviewed,26,28,29 but many of them do not consider AA or sugars, and some
molecular descriptors are not easy to understand physically. The linear-solvat-
ion energy relationship developed by Hoover and collaborators30 is one of the
most useful and comprehensive; equations have been derived for about 50
solvents and molecular descriptors for more than 3000 common organic and
pharmaceuticals compounds have been calculated for solubility predictions.
Recently, Sun9 presented a more universal method, proposing atom types
molecular descriptors to build predictive models for different properties,
including log S.
These methods are all difﬁcult to compare since they are based on different
sets of experimental data. The usual strategy is to evaluate the predictive ability
of the different methods to a test set, constituted by 21 different drugs and
pesticides. Very good results on deviations for log S were obtained using the
NN28 and Sun9 methods. As far as accuracy is concerned one cannot ask for
much better results since it strongly depends on the uncertainty of the exper-
imental measurements of log S which, for complex molecules, is around 0.6 log
unit.26
Experimental uncertainty may be attributed to substance purity, different
aspects related to the solid phase, pH and temperature control, and the method
used. Givand and collaborators31 developed studies on the inﬂuence of iso-
morphic impurities in the crystal purity of AA which is intimately linked to the
relative solubility ratio and type of solvent. Other studies emphasize the
importance of the solid-phases analysis32,33 and the method chosen for the
measurements. In fact, as shown in Figure 1, the equilibrium solubilities
obtained by the cooling and the isothermal experimental methods present
quite different results for the L-isoleucineþL-valineþwater system at 298 K.
Analyzing the solid phase, and applying mass balances, the authors concluded
that the cooling method gives more consistent results.
Several different models have been proposed to represent thermodynamic
properties of aqueous solutions of AA, namely, solubility and activity coeﬃ-
cients, with or without a presence of an electrolyte.34 Although some progress
has been achieved, the complexities that arise from the zwitterionic nature of
AA in aqueous solution, make it a difﬁcult task, and generally, it is not possible
to calculate accurately the solubilities using activity coefﬁcient data only. The
fact that AA are the building blocks of more complex molecules such as
antibiotics, peptides, or proteins, makes the understanding of the effect of
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electrolytes on the properties of aqueous AA solutions very important and
attractive, as it may give insights into processes such as salt-induced precipi-
tation of proteins. Figure 2 shows the effect of KCl on the glycine solubility in
aqueous solution at 298.15 K.
The experimental results presented by Khoshkbarchi and Vera35 and Ferre-
ira et al.34 are considerably different, which, once more, stresses the need of
careful experimental planning. For that particular system, Khoshkbarchi and
Vera35 applied an equation based on the perturbation theory to correlate their
activity coefﬁcient data, but concluded they had to use an empirical correction
to explain the solubility behavior, based on the observed effect of KCl on the
crystallographic form of the AA. Alternatively, Ferreira et al.34 correlated the
same activity coefﬁcient data, but with a modiﬁed form of the Pitzer–Simon-
son–Clegg equations,36 and predicted the solubility assuming unchanged solid
phase. The prediction curve is also included in Figure 2, suggesting a higher
adequacy of their measured solubility data. Hamelink et al.,37 in their studies
about the effect of NaCl on the activity coefﬁcients of antibiotics could not ﬁnd
a difference in the crystallographic structure of the solid phase formed by
precipitation from electrolyte antibiotic solutions to explain the solubility
behavior.
These studies are all important for a proper understanding of complex
systems involving biomolecules, and might be useful for the investigation on
protein solubility and crystallization. These questions are correlated, and rather
complex, since protein crystallization/solubility depends on many factors such
as pH, ionic strength, salt or protein type, temperature, surface hydrophobicity,
and charge distribution, etc., but extremely useful to identify, rationally, the
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Figure 1 Solubility in the L-isoleucineþL-valineþwater system at 298 K: comparison of
the cooling and the isothermal experimental methods.32
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optimal conditions for protein crystallization, reducing considerably the cost of
a trial and error process. One interesting new effective predictive tool for
protein crystallization is the introduction of the ‘‘crystallization slot’’ concept,
which associates protein crystallization with the osmotic second virial coeﬃ-
cient (SVC–B22). It can be brieﬂy summarized in the following conservative
way; while protein crystallization is very difﬁcult for positive SVC values, it is
favorable for negative values up to 103 mol ml g2, but do not guarantee
successful crystal growth.38 Although SVC is a thermodynamic property of
dilute protein solutions, Guo et al.39 have shown experimentally that it is also
correlated with protein solubility. Figure 3(a) shows the surprising results when
plotting these two variables for aqueous solutions of lysozyme obtained at
different pH, temperature, salt type and concentration.
The link between those experimental observations and theory has been
carried out by Haas et al.,43 who used two different protein interaction
potentials, and Rupert et al.,44 who derived a two-parameter correlation based
on classical thermodynamics, to represent the relation between solubility and
SVC changing composition, temperature, or pH. Experimental determination
of SVC by different methods like static or dynamic light scattering,45,46 self-
interaction,38,41 or size-exclusion,38 chromatography, can give, however, dif-
ferent values for the same protein under the same conditions. Figure 3(b) gives
the SVC for lysozyme at different NaCl concentrations presenting considerable
differences. The subject is delicate, since anisotropy effects are much relevant,47
for instance, the substitution of a single AA in a protein may introduce big
changes in the SVC values measured. Therefore, in this active research area it
will be fundamental to have the development of more reliable methods, and the
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Figure 2 Comparison of glycine solubility in water/KCl solutions at 298.15 K. The line
represents prediction34 using activity coefﬁcient data only.
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extension of the conclusions for different proteins. Two different modeling
approaches worth mention are the use of the UNIQUAC48 equation to model
protein solubility, and the neural network technology for protein crystalliza-
tion, recently reviewed by DeLucas et al.49 The lecture given by Prausnitz50 on
molecular thermodynamics for proteins in aqueous solution is highly recom-
mended.
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Figure 3 (a) Experimental correlation between SVC and solubility for aqueous solutions
of lysozyme; (b) Comparison of experimental results for SVC in aqueous
lysozyme solutions at different NaCl molalities.
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20.4 Organic and Mixed Solvent Solubility
Either for extraction, crystallization, or drug formulation purposes the study of
co-solvency is common in pharmaceutical companies. Similarly, for water
solubility, several methods have been proposed to calculate, and predict, the
solubility of biomolecules in organic or mixed solvent systems. One attractive
approach is the so-called log-linear model;11 it presents two speciﬁc co-solvent
parameters, and as far as the substance Pow and water solubility are known, the
solubility of a drug can, in principle, be estimated for an aqueous mixed solvent
system. It has, however, a major deﬁciency as it cannot predict, or even
correlate, solubility in systems like water/ethanol with caffeine, that present
maxima51 over the whole solvent composition range. The application of group-
contribution methods is an alternative, but many group interactions relevant
for pharmaceutical compounds are missing. Thus, the MOSCED (Modiﬁed
Separation of Cohesive Energy Density) developed by Lazzaroni et al.52 is a
good alternative since group interaction parameters are not needed. Using a
large number of data for activity coefﬁcients at inﬁnite dilution (gN), 5
parameters were correlated for each of the 133 solvents studied. The MOSCED
parameters for a given drug can easily be obtained if a few binary solubility
data (the authors suggest 5–8 data points in chemically diverse solvent set) are
available. After those are used to calculate the gN’s, and from their values the
Wilson or UNIQUAC16 interaction parameters can be obtained, making
possible the calculation of the solubility in all the mixed solvent composition
range. A major drawback, as explained before, is that the melting properties
must be known, and most probably, for many solutes, the data used to obtain
the MOSCED parameters are too far from inﬁnite dilution conditions. Nev-
ertheless, for 26 solutes studied, an average absolute deviation (AAD) of 24.9%
was found in the correlation of 700 solubility data points. Another method,
perhaps one of the most used in the pharmaceutical industry, is the regular
solution theory,16 where the solubility is a function of the solvent solubility
parameter. Often, a maximum in solubility is found, which corresponds both to
the ideal solubility, and to the equality between solvent and solute solubility
parameters. Again, solute-melting properties must be available, and even if for
some solutes, like morphine in different solvents, the prediction is of high
quality, for an hetero-atomic compound, the inadequacy of the method can be
extremely pronounced.1 In fact, in some very good solvents, the solute solu-
bility can exceed significantly the ideal solubility, which is totally impossible to
predict with the model.
Avoiding some of the disadvantages pointed out in the previous paragraphAQ1 ,
Abildskov and O’Connell27 developed an ingenious reference solvent method-
ology. It involves the selection of a solvent, the ‘‘optimal solvent’’, which allows
the calculation of the solute solubility in another solvent so long as the
solubility in the optimal solvent and a predictive activity coefﬁcient model,
are available. In practice, the optimal solvent is found by a trial and error
procedure, minimizing the difference (for a set of solvents) between the exper-
imental solubility in a given solvent, and that calculated for the same solvent
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using the reference solvent approach. The UNIFAC16 method was selected to
calculate the activity coefﬁcients, and for cases where the interaction param-
eters are unknown, a sensitivity analysis in terms of the more relevant param-
eters is suggested, reducing considerably the experimental measurements
needed. The results are really promising except, perhaps, when the solubility
is very high. Extensions for mixed solvent systems,53 and the inclusion of the
temperature inﬂuence on the solubility temperature dependency54 were recently
proposed.
For the special case of amino acids, Orella and Kirwan55 ﬁrst suggested the
use of the excess solubility approach to correlate the solubility of several amino
acids in water/propanol and water/isopropanol mixtures with the Wilson
model, obtaining an average relative deviation (ARD) of about 15.3%. Fol-
lowing on, Gude et al.,56,57 used the same approach, but combining the Flory–
Huggins (FH) theory with a Margules residual expression. Their method is very
simple and attractive since the authors claim the use of a unique speciﬁc
Margules parameter for each amino acid in all aqueous alkanol solutions,
which allows a straightforward prediction of amino acid solubilities in alkanol/
water solvents systems. However, applying their method to the description of
the solubility of amino acids in water/methanol solvents, which are usually the
easiest to correlate, the ARD found was 27.7%. To the best of our knowledge,
the work by Ferreira et al.,58 is the more comprehensive in this subject. Within
the framework of the excess solubility approach, the NRTL model was applied
for the correlation of the solubility of a large number of amino acids in several
alkanol/water solvents. The temperature effect was included for some speciﬁc
amino acids, and some predictions were made. The ARDs were 8.4% for
correlation and 15% for predictions. Figure 4(a) compares the results achieved
by Gude et al.56 using the FHþMargules approach, with the NRTL results
obtained by Ferreira et al.,58 for the ratio between the solubility of the AA in
the mixed solvent to that in pure water (relative solubility). A better agreement
was found with the NRTL model for the solubility of the AA in aqueous 1-
butanol solutions. Figure 4(b) shows the very good results for the prediction of
glycine solubility in aqueous ethanol solutions at two different temperatures
outside the temperature range used in the correlation.
Regarding carbohydrates, the increasing interest for food technology appli-
cations caused a great demand for predictive methods for both aqueous and
mixed solvent solutions. In the last decade two kinds of approaches were
proposed in the literature: molecular models and group-contribution meth-
ods.59 Two modiﬁed UNIQUAC equations are available: the model presented
by Peres and Macedo,60 that uses fewer parameters for each sugar–water pair
and adopts the symmetric convention, and allows a straightforward extension
to mixed solvent systems. This is not possible with the other model suggested by
Catte´ et al.61 These authors chose the unsymmetric convention for the activity
coefﬁcients calculations. The major trend in recent modeling research is,
however, based on the group-contribution methodology.
Different UNIFAC-based models are available for the prediction of solubili-
ties in sugar solutions.59 Some of the UNIFAC parameters have even been
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predicted theoretically with methods of molecular mechanics.62 The drawback
of these models is the lack of accuracy at very high sugar concentrations (>
90%wt), as has recently been pointed out.63 The reason for this lies in the fact
that the majority of the data available does not cover this range of composition.
To improve predictions of solubility in sugar solutions at these ranges of
composition, new data were measured and a four-sufﬁx Margules equation
with temperature dependent parameters was presented in the literature,63 as
well as a new physical–chemical model.64 This model takes account for the
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Figure 4 (a) Relative solubilities of amino acids in water/1-butanol solutions at 298.15 K:
comparison between the NRTL58 and FHþMargules56 models; (b) NRTL58
predictions for the relative solubilities of glycine in water/ethanol solutions.
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hydration equilibrium of carbohydrates with the formation of carbohydrate n-
water molecules and uses a UNIFAC model to describe the physical interac-
tions. Although these very recent studies try to correct deﬁciencies found in
other UNIFAC-based models, it is recognized63 that the A-UNIFAC method
developed by Ferreira et al.65 is the tool with stronger theoretical foundations,
allowing for a better capacity in predictive calculations. It incorporates a
speciﬁc association term, which considers hydrogen bonding for sugar, water
and other solvents molecules.
This section cannot be concluded without a brief mention of the innovative
features of the NRTL-SAC model proposed by Chen and Song.66 In this model
the liquid non-idealities are described in terms of three types of conceptual
segments of the molecules; hydrophobic, polar, and hydrophilic. Using refer-
ence substances for each type of segment, (hexane, water, and acetonitrile,
respectively) an extensive binary VLE and LLE database, focused on the 62
solvents most used in the pharmaceutical industry, was used to estimate the
number of conceptual segments required in each solvent. Following on, with a
few selected solubility data values of the target solute, its number of conceptual
segments can be calculated readily, and the solubility prediction in other
solvents and mixed solvents is straightforward. As it requires some well-chosen
data, NRTL-SAC is, like MOSCED and the reference solvent method, a
hybrid-data estimation method that should be encouraged.67 Its ability to
model complex pharmaceuticals organic electrolytes has been already demon-
strated,68 and the potentialities to describe solubility of other types of solutes
seems immense.
20.5 Liquid–Liquid Solubility
In the previous sections the importance of Pow as a fundamental parameter for
the estimation of solubilities in a variety of solvents has been stressed. Ther-
modynamics and extra-thermodynamics aspects of partitioning as well as its
experimental and calculating methods were recently carefully reviewed by
Sangster.69 Owing to the uncertainty in the experimental Pow values, Sangster
also presents a list of recommended values for about 500 organic compounds.
Thus, only the review by Derawi et al.70 on group-contribution methods is
brieﬂy focused. Five different UNIFAC-based methods were compared, and
the WATER UNIFAC,71 and UNIFAC LLE72 were recommended. These
models, however, present a small number of interaction parameters available,
and this inhibits their application for some functional groups like amines. For
highly hydrophobic compounds, all the UNIFAC models underestimate Pow,
and generally, for AA, their derivatives, and sugars, Pow is overestimated. The
authors believe that for multifunctional compounds the group-contribution
concept has limited capacity for further developments, and also that the atom/
fragment correlation (AFC) method73 showed superior performance in all cases
studied. This method, similarly to the one proposed by Sun9 (Section 3), allows
the calculation of both Pow and solubility by building a substance from atom
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descriptors. In the AFC method MLR was applied to derive fragment coeﬃ-
cients and correction factors using 2473 Pow in the training set, and around
10,600 for the validation of the method. The results seem really remarkable as it
is possible to take into account steric interactions, hydrogen bondings, and
even for zwitterionic species like ampicillin, amoxycillin, or peptides, values of
Pow can be estimated. A free online interactive demonstration to calculate Pow
is available at http://www.syrres.com/esc/kowdemo.htm.
Despite the increase and progresses achieved in the research work on ATPS,
so far the studies are rather scattered, making the knowledge of the mechanisms
of solute partitioning, limited. This is probably one of the main reasons for the
reluctance in its commercial exploitation.74 Traditionally, protein partitioning
has been studied in polyethyleneglycol (PEG)/dextran or PEG/(phosphate or
sulfate) salt, and the factors to consider, beyond those mentioned earlier for
protein crystallization, must now include some characteristics of the poly-
mer(s). The implementation of general rules to choose the best ATPS and the
best operating conditions for a given separation, will make practical applica-
tions simpler. However, making those rules accessible depends much on how
these different factors are understood. Recently, some interesting attempts have
been made: Lin et al.75 studied the inﬂuence of polymer concentration and
molecular weight; Andrews et al.76 focused on the protein charge and surface
hydrophobicity, which was also done by Tubio et al.77 However, no general
trend was found. Even if a relationship between the hydrophobic character of
the partitioned substance and its partitioning coefﬁcient was found the general
picture is, when studying polymer molecular weight effects the conclusions are
limited to certain proteins, and studying the protein surface hydrophobicity
effects, the results are restricted to certain values of the polymer molecular
weight.
Though much more experimental work is needed, the application of molec-
ular thermodynamics to this kind of problems must have the highest priority.
In the recent past, several different approaches have been proposed concerning
protein, peptides, and AA partition in ATPS. This was recently reviewed brieﬂy
by Jiang and Prausnitz,78 who also derived a model that takes into account,
successfully, the different partitioning behavior of native and denatured pro-
teins. One of the most recent studies on protein partitioning, and perhaps the
most comprehensive, is due to Madeira et al.79 Their modiﬁed Wilson model,
based on the lattice theory and the two-ﬂuid theory, was successively applied to
the representation of electrolyte solutions, water activity in aqueous polymer
solutions, and polymer/polymer or polymer/salt ATPS. A Debye-Hu¨ckel term
was included to take into consideration the long-range nature of the electro-
static forces in solution, and the authors end up with a model where only the
interactions involving proteins are needed to calculate protein partitioning. To
simplify, Madeira et al.79 ﬁxed those at zero, and calculated the partition of
four different proteins in Na2SO4/PEG6000 and K2HPO4/PEG6000 by adjust-
ing the protein net charge. Globally, the results may be considered very
reasonable even if in some cases large discrepancies were found between the
experimental and the calculated net charge. That is not the case for the
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partitioning behavior of lysozyme in K2HPO4/PEG6000 aqueous system at
298.15 K shown in Figure 5. Here the published experimental value for the net
charge is two, and it produces much higher deviations on the calculated
partition coefﬁcient than that obtained using the ﬁtted value of four for the
net charge. The complexity of the problem and the lack of data remain as the
major reasons for the development of more efﬁcient predictive tools for protein
partitioning on ATPS. However, some useful insights from protein crystalli-
zation must also be considered, and as it is expected that ATPS will be extend
into food and cosmetic industries,74 these problems will continue to draw
attention in the near future.
20.6 Solubility in Supercritical Fluids
Contrary to the work on the ATPS, most of the studies on SFE started in the
area of food technology. In fact, around 125 industrial scale SFE units are in
operation,80 and some of those applications were reviewed by Knox.81 The
studies are now spreading into the area of drug processing that is currently a
very popular research area, namely, on the puriﬁcation, crystallization, or
micronization of pharmaceuticals. In this context, a review on techniques such
as rapid expansion supercritical solution, or gas anti-solvent system is given
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Figure 5 Inﬂuence of the protein net charge (z) on the lysozyme partition coefﬁcient
calculation, by a modiﬁed Wilson model,79 in K2HPO4/PEG6000 aqueous
system at 298.15 K.
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eslsewhere.80,82
The large majority of the studies concern the solubility of a solute in carbon
dioxide. Some supercritical measurements on other systems such as the solu-
bility of solid mixtures and the solubility in solvents other than carbon dioxide
(and co-solvency) are also available.83–85 To correlate solubilities, empirical
equations have usually been applied, and the Chrastil equation86 is one of the
most often used. Several other empirical equations have been proposed through
the years, and some were recently compared for solute solubility in carbon
dioxide by Jouyban et al.87 Avoiding the difﬁculties of calculating some
physicochemical properties, the authors only compared equations for which
the independent variables are readily accessible, e.g., temperature, pressure,
and pure solvent density promoting, in this way, their usefulness. A six
parameter equation, developed by the authors, showed the best performance
with an AAD of 21.4% for the 106 systems compiled in their database. This is
comparable to the experimental uncertainty.
Several different equations of state (EoS) have also been applied, but a major
difﬁculty arises from the need to know solute critical properties, vapor pressure,
and density. Unfortunately, for many substances those are impossible to
measure because the solute decomposes, and estimating methods must be
applied for their evaluation. However, different methods give, naturally, dif-
ferent values for those properties, which may have a lot of inﬂuence in the
correlation abilities of the EoS and, what is worse, can produce poor and
sometimes impossible results.88 Furthermore, relatively small variations in the
properties can cause large differences in the predicted solubilities,89 and so, a lot
of caution must be taken in the choice of methods used. Another issue that
must be considered carefully when modeling solubilities is the stability of the
results. In a very enlighten work, Xu et al.90 developed a strategy, and gave
some good examples, about the need of considering the iso-fugacity condition
simultaneously with a check on global thermodynamic phase stability by
applying tests such as tangent plane analysis and global minimization meth-
odologies. Cubic EoS like Soave–Redlich–Kwong and Peng–Robinson are,
surely, the most used, but for rigorous calculations of solubilities in these type
of systems much more work is imperative. Nevertheless, even if accurate
general conclusions are not possible at this time, cubic EoS that uses free
energy models in its parameters and non-quadratic mixing rules, with interac-
tion parameters in the volume constants, give the best results.91 Finally, taking
into consideration the results already achieved with the group-contribution
associating EoS,92 the research on the potential of association ﬂuid theories is
also highly recommended.
20.7 Conclusions
A global overview about current solubility issues for food, pharmaceutical, and
cosmetic industries has been given. Great progress has been achieved for solute
solubility in water and organic solvents as well as for water–octanol partition
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coefﬁcients, but the potentialities of some very recent models and methods, e.g.,
reference solvent methodology or NRTL-SAC model, should be extensively
explored. Nevertheless, constant evolution in those industries will stress the
need for new measurements and advances for innovative experimental tech-
niques. The development of a solubility database and a measurement strategy,
perhaps, as suggested by Kola´rˇ et al.,1 is highly recommended, but applications
of relatively novel compounds like ionic liquids or cyclodextrins should also be
taken into account for the development of new processes. A very interesting
progress on protein crystallization has also been achieved with the ‘‘crystalli-
zation slot’’ concept that should be applied to several different systems.
Understanding the behavior of simple molecules like AA and small peptides
in aqueous electrolyte solutions can also be useful for further developments. As
far as ATPS are concerned some interesting studies have brieﬂy been discussed.
However, the development of alternative ATPS as well as much more inform-
ative models capable of explaining mechanisms under protein partitioning is
fundamental to make the technique attractive to industries. That is also an issue
for simulation SFE processes, but EoS for associating ﬂuids might be a very
useful tool. In fact, some particular difﬁculties pointed out for solubility
modeling in supercritical ﬂuids make it a hard task, and an analysis for
methods to estimate solute properties must be taken into account. Finally, it
is consensual that, generally, understanding solubility phenomena may beneﬁt
very much from molecular simulation data.
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